Myrexis Cmn Stk Stock EBITDA
| MYRXDelisted Stock | USD 0 0.00 0.00% |
Myrexis Cmn Stk fundamentals help investors to digest information that contributes to Myrexis Cmn's financial success or failures. It also enables traders to predict the movement of Myrexis Pink Sheet. The fundamental analysis module provides a way to measure Myrexis Cmn's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Myrexis Cmn pink sheet.
Myrexis |
Myrexis Cmn Stk Company EBITDA Analysis
Myrexis Cmn's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Myrexis Cmn EBITDA | (10.8 M) |
Most of Myrexis Cmn's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Myrexis Cmn Stk is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
CompetitionAccording to the company disclosure, Myrexis Cmn Stk reported earnings before interest,tax, depreciation and amortization of (10.8 Million). This is 100.02% lower than that of the Biotechnology sector and significantly lower than that of the Health Care industry. The ebitda for all United States stocks is 100.28% higher than that of the company.
Myrexis EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Myrexis Cmn's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Myrexis Cmn could also be used in its relative valuation, which is a method of valuing Myrexis Cmn by comparing valuation metrics of similar companies.Myrexis Cmn is currently under evaluation in ebitda category among its peers.
Myrexis Fundamentals
| Return On Equity | -0.26 | ||||
| Return On Asset | -0.15 | ||||
| Current Valuation | 3.93 M | ||||
| Shares Outstanding | 34.48 M | ||||
| Shares Owned By Institutions | 1.25 % | ||||
| Number Of Shares Shorted | 48.45 K | ||||
| Price To Earning | (0.10) X | ||||
| Price To Book | 4.42 X | ||||
| EBITDA | (10.8 M) | ||||
| Net Income | (11.62 M) | ||||
| Cash And Equivalents | 1.21 M | ||||
| Cash Per Share | 0.04 X | ||||
| Debt To Equity | (1.51) % | ||||
| Current Ratio | 16.72 X | ||||
| Book Value Per Share | 0.03 X | ||||
| Cash Flow From Operations | (12.97 M) | ||||
| Short Ratio | 0.39 X | ||||
| Earnings Per Share | (0.39) X | ||||
| Target Price | 5.0 | ||||
| Beta | 2.49 | ||||
| Market Capitalization | 4.14 M | ||||
| Total Asset | 1.24 M | ||||
| Retained Earnings | (128.49 M) | ||||
| Working Capital | 1.16 M | ||||
| Current Asset | 1.24 M | ||||
| Current Liabilities | 74 K | ||||
| Net Asset | 1.24 M |
About Myrexis Cmn Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Myrexis Cmn Stk's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Myrexis Cmn using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Myrexis Cmn Stk based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Other Consideration for investing in Myrexis Pink Sheet
If you are still planning to invest in Myrexis Cmn Stk check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Myrexis Cmn's history and understand the potential risks before investing.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |